Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders | Journal of Medicinal Chemistry
![A summary of the information to be developed before the selection of a... | Download Scientific Diagram A summary of the information to be developed before the selection of a... | Download Scientific Diagram](https://www.researchgate.net/publication/321009122/figure/fig2/AS:573452308279297@1513733092370/A-summary-of-the-information-to-be-developed-before-the-selection-of-a-clinical-candidate.png)
A summary of the information to be developed before the selection of a... | Download Scientific Diagram
![Targeting Your Best Clinical Candidate With Self Guided Data Discovery and Analysis | Technology Networks Targeting Your Best Clinical Candidate With Self Guided Data Discovery and Analysis | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/298448/targeting-your-best-clinical-candidate-with-self-guided-data-discovery-and-analysis-298448-1280x720.jpg?cb=9631209)
Targeting Your Best Clinical Candidate With Self Guided Data Discovery and Analysis | Technology Networks
Excelya - {A real-time dashboard of clinical trials for COVID-19} In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial research assessing the efficacy and safety of clinical candidate interventions
![Flow chart for follow-up activities towards a pre-clinical candidate.... | Download Scientific Diagram Flow chart for follow-up activities towards a pre-clinical candidate.... | Download Scientific Diagram](https://www.researchgate.net/profile/Ujjini-Manjunatha/publication/270008205/figure/fig3/AS:267650920087606@1440824360971/Flow-chart-for-follow-up-activities-towards-a-pre-clinical-candidate-MDR-multi-drug.png)
Flow chart for follow-up activities towards a pre-clinical candidate.... | Download Scientific Diagram
![POP Seminar Guest Speaker/Faculty Clinical Candidate: Clayton Johnston, PharmD, MBA, MA, MEd, FACHE, FHFMA on 04/04/2022 » Department of Pharmaceutical Outcomes & Policy » College of Pharmacy » University of Florida POP Seminar Guest Speaker/Faculty Clinical Candidate: Clayton Johnston, PharmD, MBA, MA, MEd, FACHE, FHFMA on 04/04/2022 » Department of Pharmaceutical Outcomes & Policy » College of Pharmacy » University of Florida](https://pop.pharmacy.ufl.edu/wordpress/files/2022/04/20220404-POP-Seminar-Announcement-Johnston.png)
POP Seminar Guest Speaker/Faculty Clinical Candidate: Clayton Johnston, PharmD, MBA, MA, MEd, FACHE, FHFMA on 04/04/2022 » Department of Pharmaceutical Outcomes & Policy » College of Pharmacy » University of Florida
![PDF] Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. | Semantic Scholar PDF] Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/74492283f9f1220825f1b826a51ce46ef9c11f94/3-Figure1-1.png)
PDF] Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. | Semantic Scholar
![Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia - ScienceDirect Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2329050121000838-fx1.jpg)
Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia - ScienceDirect
![Sosei Heptares Announces That The Third Novel Drug Candidate From Its Multi-target Drug Discovery Collaboration With Pfizer Has Started Clinical Trials Sosei Heptares Announces That The Third Novel Drug Candidate From Its Multi-target Drug Discovery Collaboration With Pfizer Has Started Clinical Trials](https://www.prittleprattlenews.com/wp-content/uploads/2021/05/Sosei-Heptares-announces--990x557.jpg)
Sosei Heptares Announces That The Third Novel Drug Candidate From Its Multi-target Drug Discovery Collaboration With Pfizer Has Started Clinical Trials
![Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate | Nature Communications Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms7715/MediaObjects/41467_2015_Article_BFncomms7715_Fig2_HTML.jpg)
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate | Nature Communications
![Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer | Business Wire Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer | Business Wire](https://mms.businesswire.com/media/20220428006002/en/1436959/23/Crown_Bioscience_Logo_-_TEAL.jpg)